The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users

[1]  M. Abdel-Hamid,et al.  The Effects of Acute Tryptophan Depletion on Reactive Aggression in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) and Healthy Controls , 2012, PloS one.

[2]  T. Robbins,et al.  Converging evidence for central 5-HT effects in acute tryptophan depletion , 2012, Molecular Psychiatry.

[3]  T. Robbins,et al.  Effects of Acute Tryptophan Depletion on Prefrontal-Amygdala Connectivity While Viewing Facial Signals of Aggression , 2012, Biological Psychiatry.

[4]  P. Kelly,et al.  Mechanism of acute tryptophan depletion: is it only serotonin? , 2011, Molecular Psychiatry.

[5]  D. Nutt,et al.  Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls , 2009, Psychopharmacology.

[6]  B. Sahakian,et al.  Acute tryptophan depletion evokes negative mood in healthy females who have previously experienced concurrent negative mood and tryptophan depletion , 2009, Psychopharmacology.

[7]  B. Roth,et al.  The expanded biology of serotonin. , 2009, Annual review of medicine.

[8]  W. van den Brink,et al.  Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. , 2008, Brain : a journal of neurology.

[9]  L. Johnston,et al.  Monitoring the Future national survey results on drug use, 1975-2017: Volume II, college students and adults ages 19-55 , 2008 .

[10]  J. Redman,et al.  Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? , 2007, Neuroscience & Biobehavioral Reviews.

[11]  Patrick M. O'Malley,et al.  Monitoring the Future: National Survey Results on Drug Use, 1975-2006. Volume II: College Students & Adults Ages 19-25. NIH Publication No. 07-6206. , 2007 .

[12]  A. Schene,et al.  Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies , 2007, Molecular Psychiatry.

[13]  B. Sahakian,et al.  Neuropsychological function in ecstasy users: a study controlling for polydrug use , 2006, Psychopharmacology.

[14]  R. Rogers,et al.  Elevated Impulsivity and Impaired Decision-Making in Abstinent Ecstasy (MDMA) Users Compared to Polydrug and Drug-Naïve Controls , 2006, Neuropsychopharmacology.

[15]  Liesbeth Reneman,et al.  Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects , 2006, Journal of psychopharmacology.

[16]  A. Bechara,et al.  Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls , 2006, Journal of psychopharmacology.

[17]  R. Buchert,et al.  Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective , 2006, Journal of psychopharmacology.

[18]  A. Bond,et al.  An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood – are there gender differences? , 2006, Journal of psychopharmacology.

[19]  W. van den Brink,et al.  Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study , 2006, Journal of psychopharmacology.

[20]  F. Verhulst,et al.  Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study , 2006, BMJ : British Medical Journal.

[21]  R. Buchert,et al.  Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  W. Maier,et al.  Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”) , 2006, Psychopharmacology.

[23]  L. Johnston,et al.  Monitoring the Future national survey results on drug use, 1975-2018: Volume II, college students and adults ages 19-60 , 2005 .

[24]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[25]  S. Kish,et al.  Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). , 2004, Journal of forensic sciences.

[26]  D. Yurgelun-Todd,et al.  Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. , 2004, Drug and alcohol dependence.

[27]  R. Croft,et al.  Chronic MDMA (ecstasy) use, cognition and mood , 2004, Psychopharmacology.

[28]  A. Parrott.  Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity , 2004, Psychopharmacology.

[29]  E. Gouzoulis-Mayfrank,et al.  Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation , 2004, Psychopharmacology.

[30]  M. Colado,et al.  The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) , 2003, Pharmacological Reviews.

[31]  L. Parsons,et al.  MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys , 2003, Pharmacology Biochemistry and Behavior.

[32]  H. Curran,et al.  Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function , 2003, Psychopharmacology.

[33]  Patrick M. O'Malley,et al.  Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004. , 2003 .

[34]  H. Wittchen,et al.  Mental disorders in ecstasy users: a prospective-longitudinal investigation. , 2002, Drug and alcohol dependence.

[35]  Marco Leyton,et al.  The role of serotonin in human mood and social interaction Insight from altered tryptophan levels , 2002, Pharmacology Biochemistry and Behavior.

[36]  V. Curran,et al.  Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences , 2002, Psychopharmacology.

[37]  Liesbeth Reneman,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[38]  G. Laviola,et al.  Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates. , 2001, Journal of substance abuse.

[39]  E. Gouzoulis-Mayfrank,et al.  Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use , 2001, Human psychopharmacology.

[40]  A. Parrott,et al.  Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history , 2001, Human psychopharmacology.

[41]  Camellia P. Clark,et al.  Clinical and Physiological Consequences of Rapid Tryptophan Depletion , 2000, Neuropsychopharmacology.

[42]  P. Delgado,et al.  Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes , 2000, Biological Psychiatry.

[43]  U. McCann,et al.  (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals , 2000, Neuropsychobiology.

[44]  C. Benkelfat,et al.  Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. , 1999, The American journal of psychiatry.

[45]  D. Murphy,et al.  Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users , 1999, Psychopharmacology.

[46]  S. Kasper,et al.  Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder? , 1999, International clinical psychopharmacology.

[47]  U. McCann,et al.  Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study , 1999, Psychopharmacology.

[48]  Z. Szabo,et al.  Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.

[49]  C. Benkelfat,et al.  Tryptophan Depletion, Executive Functions, and Disinhibition in Aggressive, Adolescent Males , 1998, Neuropsychopharmacology.

[50]  C. McDougle,et al.  Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.

[51]  M Diksic,et al.  Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Pihl,et al.  Assessment of measures of impulsivity in healthy male volunteers , 1995 .

[53]  G. Goodwin,et al.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) , 1995, Psychopharmacology.

[54]  R. Pihl,et al.  Acute effect of altered tryptophan levels and alcohol on aggression in normal human males , 1995, Psychopharmacology.

[55]  A. Bond,et al.  The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects , 1995, Psychopharmacology.

[56]  C. Benkelfat,et al.  Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. , 1994, Archives of general psychiatry.

[57]  Y. Shaham,et al.  Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans , 1994, Neuropsychopharmacology.

[58]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[59]  J. Newman,et al.  Reaction to punishment in extraverts and psychopaths: Implications for the impulsive behavior of disinhibited individuals , 1987 .

[60]  M. Lorr,et al.  Evidence for bipolar mood states. , 1982, Journal of personality assessment.

[61]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[62]  S. Taylor.  Aggressive behavior and physiological arousal as a function of provocation and the tendency to inhibit aggression. , 1967, Journal of personality.

[63]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[64]  G. Plasse.  Converging evidence for central 5-HT effects in acute tryptophan depletion? , 2013, Molecular Psychiatry.

[65]  B. Schmand,et al.  Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users , 2009, Psychopharmacology.

[66]  R. Pihl,et al.  Tryptophan depletion causes a rapid lowering of mood in normal males , 2004, Psychopharmacology.

[67]  A. Bond,et al.  Angry cognitive bias, trait aggression and impulsivity in substance users , 2004, Psychopharmacology.

[68]  C. Fahlke,et al.  Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission. , 2002, Drug and alcohol dependence.

[69]  P. Restani,et al.  Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures. , 1991, Life sciences.

[70]  M. Lorr,et al.  Manual for the Profile of Mood States , 1971 .

[71]  B. Pitt.  Psychopharmacology , 1968, Mental Health.